Erfonrilimab: all 21 studies that test it
Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GCRecruitingNCT06023758Phase 2
- The Efficacy and Safety of KN046 Combined With AxitinibRecruitingNCT06020352Phase 2/3
- Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic CancerRecruitingNCT05832892Phase 1/2
- A Phase Ib/II Study of GT90001 Combined With KN046 in Solid TumorsRecruitingNCT04984668Phase 1/2
- A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint InhibitorsTerminatedNCT04925947Phase 2Results posted
- KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 BlockadeActive, not recruitingNCT06099821Phase 2
- KN 046 Plus Regorafenib in MSS Metastatic Colorectal CancerTerminatedNCT05985109Phase 2
- Study of KN046 in Subjects With Advanced Non-Small Cell Lung CancerCompletedNCT05420220Phase 2
- KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma.Active, not recruitingNCT05149326Phase 3
- KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 AgentTerminatedNCT05001724Phase 2/3
- A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal TumorsTerminatedNCT04612712Phase 1/2
- The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular CarcinomaCompletedNCT04542837Phase 2
- KN046 in Subjects With Advanced Squamous Non-small Cell Lung CancerStatus unknownNCT04474119Phase 3
- KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic CarcinomaTerminatedNCT04469725Phase 2
- KN026 Combined With KN046 in Subjects With HER2 Positive Solid TumorCompletedNCT04040699Phase 1
- KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell CarcinomaStatus unknownNCT03927495Phase 2
- KN046 in Subjects With Late Stage Esophageal Squamous Cell CarcinomaCompletedNCT03925870Phase 2
- A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast CancerCompletedNCT03872791Phase 1/2
- KN046 in Patients With Advanced Non-small Cell Lung CancerTerminatedNCT03838848Phase 2
- KN046 in Subjects With Advanced Solid Tumors and LymphomaCompletedNCT03733951Phase 1
- Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid TumorsStatus unknownNCT03529526Phase 1